Autologous Stem Cell Transplant

Overview

Autologous Transplant is a type of stem cell transplant that utilizes the patient's pre-collected own stem cell to rescue the bone marrow from the toxic effect of a very high dose chemotherapy.

SparkCures ID 21
Generic Name Autologous Stem Cell Transplant
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autole...
CARTITUDE-6
View Trial
Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
View Trial
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
View Trial
Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified
Personalized Autologous Transplant for Multiple Myeloma
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
View Trial
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the ...
View Trial
Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the ...
View Trial
Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources